European Partnership For Alternatives To Animal Testing
This article contains contt that is writt like an advertisemt. Please help improve it by removing promotional contt and inappropriate external links, and by adding cyclopedic contt writt from a neutral point of view. (March 2012 ) (Learn how and wh to remove this template message)
This article possibly contains original research. Please improve it by verifying the claims made and adding inline citations. Statemts consisting only of original research should be removed. (March 2023 ) (Learn how and wh to remove this template message)
The European Partnership for Alternative Approaches to Animal Testing (EPAA) promotes the application of the 3Rs principles (Replacemt, Reduction, and Refinemt of animal testing) in meeting regulatory requiremts for products such as pharmaceuticals, chemicals, soaps, detergts and cosmetics. The EPAA covers research and developmt, as well as the use of 3Rs approaches in regulatory compliance and communication and dissemination.
The In Vitro Choice_ Mborras_2013
The EPAA was created in 2005. European Commissioners Janez Potocnik, Gunter Verheug and Dagmar Roth-Behrdt, the th Vice Presidt of the European Parliamt, supported the establishmt and launch of the EPAA.
The EPAA is a public-private partnership involving the European Commission (EC) and European industry sectors involved in the developmt of alternative approaches toward animal experimtation. The actions undertak by the EPAA arise from communication and cooperation betwe services of the EC and industry, focused on regulatory compliance, with the involvemt of NGOs, academia and regulators from third countries. To maintain transparcy of its activities and an external perspective, the EPAA has a mirror group composed of indepdt members from academia, animal welfare groups, laboratory animal scice associations and national authorities.
Members of the EPAA as of March, 2012 included five Directorates-Geral of the EC, 36 companies and six European trade associations represting various sectors of the industry
Repeated Dose Toxicity Testing: Report From An Epaa Partners' Forum
In rect decades, legislation aimed at the promotion of the 3Rs in regulatory testing have systematically be introduced into Europe. EU Directive 2010/63/EU
On the protection of animals used for scitific purposes. The aim of the new Directive is to strgth legislation, improve the welfare of those animals still needed to be used, as well as to firmly anchor the principles of the 3Rs in EU legislation.
In 2003, legislation introduced a ban on using animals for testing cosmetics. Currt and consolidated regulations on cosmetics and animal testing are laid down in the Cosmetics Regulation 1223/2009.
The Reprefred Society
European regulatory agcies such as the European Medicines Agcy, the European Chemicals Agcy, and the European Food Safety Authority are involved in the implemtation of EU legislation. They adopted policy documts on the 3Rs, such as the concept paper on the Need for Revision of the Position on the Replacemt of Animal Studies by in vitro Models
(CPMP/SWP/728/95) from the EMA Committee for Medicinal Products for Human Use, the EFSA opinion on Existing approaches incorporating replacemt, reduction and refinemt of animal testing: applicability in food and feed risk assessmt
EPAA industry partners, interested in global approaches, provide input and data to the international harmonization process to achieve international regulatory convergce. EPAA partners also carried out a feasibility study allowing the Organisation for Economic Co-operation and Developmt (OECD) to adopt its guideline on the extded one geration reproductive toxicity study. EPAA companies play a significant role with authorities in the EPAA project on the improved consistcy approach for vaccines.
Conferenza Annuale Epaa (european Partnership For Alternative Approaches To Animal Testing) Sui Metodi Alternativi
The EPAA organizes its activities around a yearly lead theme. For 2011, the lead theme was “Integrated testing strategies and their impact on the 3Rs”. The theme for 2012 was Global implemtation of 3Rs methodologies through international cooperation. The EPAA focuses on selected priority areas. Typical examples include :
European regulatory agcies such as the European Medicines Agcy, the European Chemicals Agcy, and the European Food Safety Authority are involved in the implemtation of EU legislation. They adopted policy documts on the 3Rs, such as the concept paper on the Need for Revision of the Position on the Replacemt of Animal Studies by in vitro Models
(CPMP/SWP/728/95) from the EMA Committee for Medicinal Products for Human Use, the EFSA opinion on Existing approaches incorporating replacemt, reduction and refinemt of animal testing: applicability in food and feed risk assessmt
EPAA industry partners, interested in global approaches, provide input and data to the international harmonization process to achieve international regulatory convergce. EPAA partners also carried out a feasibility study allowing the Organisation for Economic Co-operation and Developmt (OECD) to adopt its guideline on the extded one geration reproductive toxicity study. EPAA companies play a significant role with authorities in the EPAA project on the improved consistcy approach for vaccines.
Conferenza Annuale Epaa (european Partnership For Alternative Approaches To Animal Testing) Sui Metodi Alternativi
The EPAA organizes its activities around a yearly lead theme. For 2011, the lead theme was “Integrated testing strategies and their impact on the 3Rs”. The theme for 2012 was Global implemtation of 3Rs methodologies through international cooperation. The EPAA focuses on selected priority areas. Typical examples include :
Posting Komentar untuk "European Partnership For Alternatives To Animal Testing"